US Earnings Financial Results SEC Filings — July 27, 2026

27-07-2026

Ensign Group reported strong Q2 2026 results with total revenue of $1.44B, up 17.3% YoY, and net income attributable to the company of $99.7M, up 18.2% YoY. For the first half of 2026, revenue grew 17.9% to $2.83B and net income rose 21.1% to $199.4M. However, cash and cash equivalents declined sharply by 48.0% from $503.9M at year-end 2025 to $262.3M, driven by $376.0M in acquisition spending and $40.0M in share repurchases during the first half of 2026.

• · Medicaid revenue was the largest payor source at 39.6% of service revenue in Q2 2026, up 16.7% YoY to $566.8M.
• · Medicare revenue grew 16.7% YoY to $339.7M in Q2 2026, representing 23.7% of service revenue.
• · Managed care revenue increased 15.6% YoY to $265.3M in Q2 2026, accounting for 18.5% of service revenue.
• · Private and other revenue grew 28.8% YoY to $180.0M in Q2 2026, the fastest-growing payor segment.
• · Total assets increased 5.2% to $5.75B as of June 30, 2026 from $5.46B at December 31, 2025.
• · Long-term debt (less current maturities) was $135.6M, relatively flat compared to $137.5M at year-end 2025.
• · Goodwill remained unchanged at $98.0M, indicating no impairment charges.
• · Dividends declared were $0.0650 per share in both Q1 and Q2 2026, totaling $7.6M paid in H1 2026.
• · Accrued self-insurance liabilities (current and long-term) increased 27.6% to $295.8M from $246.4M at year-end 2025.
• · Accounts receivable grew 5.0% to $668.9M, with allowance for doubtful accounts of $7.9M.

27-07-2026

Clean Energy Technologies, Inc. (CETY) reported a net loss of $662,200 for Q1 2026, nearly identical to the $660,058 loss in Q1 2025. Total revenue surged 77% YoY to $783,705, driven by a massive ramp in NG Trading ($776,167 vs $3,481), but this was offset by a gross loss of $13,930 compared to a gross profit of $411,878 in the prior year, as cost of goods sold skyrocketed to $797,635 from $30,062. Cash and cash equivalents plummeted 94% to just $39,078 from $602,461 at year-end 2025, while total assets grew to $13.9M and total liabilities increased to $6.9M.

• · Operating cash flow worsened to -$836,618 in Q1 2026 from -$776,047 in Q1 2025.
• · Investing activities used $702,746 in Q1 2026, primarily for a $700,000 convertible note receivable and a $2,746 long-term investment.
• · Financing activities provided $975,557 in Q1 2026, mainly from $1,336,469 in proceeds from notes payable and lines of credit, partially offset by $395,451 in payments.
• · Derivative liability increased to $721,678 from $493,308 at year-end 2025.
• · Convertible notes payable nearly doubled to $1,794,742 from $880,052.
• · Short-term notes payable decreased sharply to $171,821 from $722,350.
• · Interest and financing fees rose to $515,128 from $348,186.
• · Other income of $584,613 was recognized in Q1 2026, largely from a change in fair value of a convertible note receivable ($435,053).
• · Heat Recovery Solutions segment swung from a profit of $235,658 to a loss of $25,223.
• · Waste to Energy segment had zero revenue in Q1 2026 vs $176,105 in Q1 2025.
• · Net loss per share improved to ($0.05) from ($0.21) due to a higher share count.

27-07-2026

Ladder Capital Corp reported net income attributable to Class A common shareholders of $14.6M for Q2 2026, down 15.8% from $17.3M in Q2 2025. For the six months ended June 30, 2026, net income was $17.2M, a 40.9% decline from $29.1M in the prior year period. Total assets grew 8.8% to $5.61B, driven by increases in mortgage loan receivables and real estate investments, while total equity decreased 3.7% to $1.43B due to dividends and share repurchases.

• · Net interest income for Q2 2026 was $22.6M, up 4.9% from $21.5M in Q2 2025.
• · Total other income for Q2 2026 was $35.2M, up 1.3% from $34.7M in Q2 2025.
• · Total costs and expenses for Q2 2026 were $41.3M, up 16.5% from $35.5M in Q2 2025.
• · Basic and diluted EPS for Q2 2026 were $0.12, down from $0.14 in Q2 2025.
• · Book value per share (total equity / shares outstanding) as of June 30, 2026 was approximately $11.24.
• · Dividends declared in H1 2026 totaled $58.5M.
• · Share repurchases in H1 2026 were $21.5M.
• · Mortgage loan receivables held for investment increased 25.8% from Dec 31, 2025 to Jun 30, 2026.
• · Securities decreased 10.3% from Dec 31, 2025 to Jun 30, 2026.
• · Debt obligations increased 14.1% from Dec 31, 2025 to Jun 30, 2026.

27-07-2026

Unity Forge Inc. reported quarter and YTD profitability for the three months ended June 30, 2026 with Revenue of $30,000 and Net Income of $7,795 for the quarter and Revenue of $52,675 and Net Income of $11,526 for the nine months ended June 30, 2026. However, the company moved from Total Assets of $9,791 as of September 30, 2025 to $16,774 as of June 30, 2026 with Liabilities decreasing from $8,000 to $0 while Stockholders' Equity increased to $16,774; some prior-period comparatives are absent (many 2025 period line items are reported as “-”), limiting full period-over-period trend analysis.

• · Unearned revenue of $8,000 existed as of September 30, 2025 but is $0 as of June 30, 2026 (change reduces liabilities to $0).
• · Company recorded capital expenditures: Payment for website development $3,000 and payment for computer $1,150 in nine months ended June 30, 2026.
• · Additional Paid-In Capital increased by $3,371 during the period and $86 of proceeds from issuance of common stock were recorded (86,426 shares issued).
• · Many comparative 2025 line items in the statements are presented as “-”, so percentage changes versus prior-year periods are not computable for several metrics (the filing lacks comparable numeric prior-period amounts).

27-07-2026

FirstCash Holdings reported strong Q2 2026 results with total revenue of $1.07B, up 29.4% YoY, and net income of $93.5M, up 56.3% YoY. However, leased merchandise income declined 17.4% YoY to $115.5M, and interest and fees on retail finance products fell 2.8% YoY to $74.0M, indicating mixed segment performance. The company also completed a $750M senior unsecured note issuance and increased share repurchases.

• · Provision for loan losses increased 6.0% YoY to $39.9M in Q2 2026, while provision for lease losses decreased 24.9% YoY to $24.4M.
• · Interest expense rose 35.6% YoY to $35.7M in Q2 2026, reflecting higher debt levels.
• · Merger and acquisition expenses were $6.4M in Q2 2026, up from $2.8M in Q2 2025.
• · The company repurchased 357 thousand shares of treasury stock in Q2 2026 for $77.4M, compared to no repurchases in Q2 2025.
• · Cash dividends increased to $0.42 per share in 2026 from $0.38 per share in 2025.
• · Net cash flow from operations was $330.4M in H1 2026, up 35.7% from $243.5M in H1 2025.
• · The company issued $750M in senior unsecured notes and repaid $60.5M in secured term loans during H1 2026.
• · Goodwill increased to $2.03B as of June 30, 2026 from $1.83B a year earlier, reflecting acquisitions.

27-07-2026

Brixmor Property Group Inc. reported mixed results for Q2 2026. Total revenues increased 4.3% YoY to $354.2M for the quarter and 4.7% to $709.0M for the six months, driven by rental income growth. However, net income attributable to the company declined 13.7% YoY to $73.5M in Q2, impacted by a $6.0M impairment charge and higher interest expense, though H1 net income rose 30.0% to $201.3M. The company also completed a $600M debt repayment and issued $398.5M in new unsecured notes during the period.

• · Impairment of real estate assets of $6.0M in Q2 2026 vs $0 in Q2 2025.
• · Gain on sale of real estate assets declined 37.7% YoY in Q2 2026 to $9.8M, but surged 228.9% to $61.9M in H1 2026.
• · Interest expense increased 11.9% YoY in Q2 2026 to $60.9M and 10.9% to $120.3M in H1 2026.
• · Cash and cash equivalents dropped 48.9% from $334.4M at Dec 31, 2025 to $170.9M at June 30, 2026.
• · Net cash provided by operating activities increased 10.7% to $344.9M in H1 2026 from $311.5M in H1 2025.
• · Net cash used in investing activities decreased to $106.3M from $149.0M, primarily due to lower improvements and investments in real estate.
• · Net cash used in financing activities was $413.9M, including $600M debt repayment and $398.5M in new unsecured notes.
• · Common stock dividends increased to $0.3075 per share in 2026 from $0.2875 in 2025.
• · Redeemable non-controlling interests of $30.6M were issued for acquisition of real estate assets.
• · Total assets decreased 1.4% from $9.13B to $9.01B.
• · Debt obligations decreased 3.1% from $5.49B to $5.32B.

27-07-2026

Sanmina Corp reported strong Q3 FY2026 results with net sales surging 69.7% YoY to $3.46B, driven by the acquisition of ZT Systems. Net income attributable to common shareholders rose 70.7% YoY to $117.1M, with diluted EPS up 68.3% to $2.12. However, operating cash flow declined significantly, and the company incurred substantial acquisition-related costs and higher interest expense, partly offsetting the top-line gains.

• · Acquisition of ZT Systems contributed $1.11B cash outflow and $155.3M in common stock issuance.
• · Goodwill increased from $30.4M to $121.9M, reflecting the acquisition.
• · Total assets nearly doubled from $5.86B to $9.74B.
• · Inventories rose 58.5% to $3.15B, while accounts receivable increased 41.9% to $1.99B.
• · Debt issuance costs of $29.3M were incurred in the nine months.
• · Restructuring charges were $1.6M in Q3 FY2026 vs $0.5M in Q3 FY2025.
• · The company repurchased $239.2M of common stock in the nine months, up from $113.9M a year ago.
• · Net revenue adjustments from favorable/unfavorable items were a net favorable $0.9M in Q3 FY2026 vs $4.9M in Q3 FY2025.

27-07-2026

Aehr Test Systems filed its annual report for the fiscal year ended May 29, 2026, reporting a net loss of $7.1M compared to a net loss of $3.9M in the prior year, while revenue declined 15.2% to $50.0M. The company strengthened its balance sheet significantly, with cash and cash equivalents increasing to $116.4M from $24.5M, driven by $97.2M in financing activities. However, gross margin contracted to 35.3% from 40.6%, and operating losses widened to $14.1M from $5.7M, reflecting ongoing challenges in the core business.

• · Operating loss widened to $14.1M in FY 2026 from $5.7M in FY 2025, driven by a $2.2M increase in R&D and a $0.9M increase in SG&A.
• · Asia revenue fell 38.5% to $22.8M and now represents 45.6% of total revenue, down from 62.9% in FY 2025.
• · United States revenue grew 16.8% to $20.6M, increasing its share of total revenue to 41.3% from 30.0%.
• · Europe and Middle East revenue grew 55.6% to $6.5M, representing 13.1% of total revenue.
• · Cash flow from operations was negative $3.3M in FY 2026, improving from negative $7.4M in FY 2025.
• · Financing activities provided $97.2M, primarily from equity issuances, boosting cash and shareholders' equity.
• · Accumulated deficit increased to $30.2M from $23.1M.
• · Restructuring charges were minimal at $6,000 in FY 2026 compared to $864,000 in FY 2025.

27-07-2026

Cincinnati Financial Corp reported strong Q2 2026 results with net income surging 83% to $1,255M ($8.14 per share) from $685M ($4.38 per share) a year ago, driven by a $1,308M net investment gain. However, the company's core underwriting results showed a more modest improvement, with earned premiums growing 6.3% to $2,635M, while insurance losses and expenses increased 13.7% to $1,887M. The company also significantly increased share repurchases, buying back $215M in stock during the quarter versus none in Q2 2025.

• · Net investment gains of $1,308M in Q2 2026 were primarily driven by $1,117M in unrealized gains on equity securities still held.
• · Prior accident year reserve development was favorable at $42M in Q2 2026, compared to $63M favorable in Q2 2025.
• · Total investments grew to $33,153M at June 30, 2026 from $31,783M at December 31, 2025.
• · The company's debt-to-equity ratio remained low with long-term debt and lease obligations of $859M against $16,671M equity.
• · Accumulated other comprehensive loss widened to $135M from $34M at year-end 2025, driven by a $116M loss in H1 2026.
• · Cash and cash equivalents increased 22.3% to $1,750M from $1,431M at year-end 2025.
• · The company repurchased 2.4 million shares in H1 2026 compared to 0.3 million in H1 2025.

27-07-2026

Navitas Semiconductor Corp reported net revenues of $10.5M for Q2 2026, down 27.3% YoY from $14.5M, and $19.1M for H1 2026, down 32.9% from $28.5M in H1 2025. The company posted a net loss of $228.2M in Q2 2026 versus a $49.1M loss in Q2 2025, driven primarily by a $203.1M non-cash loss from the change in fair value of earnout liabilities. Cash and cash equivalents surged to $557.4M as of June 30, 2026 from $236.9M at year-end 2025, boosted by $380.7M in net proceeds from at-the-market offerings, but operating cash flow worsened to a use of $48.3M in H1 2026 versus $24.8M in H1 2025.

• · Cost of revenues decreased to $6.5M in Q2 2026 from $12.2M in Q2 2025, a 47.0% decline, but gross margin remained negative on an operating basis.
• · Research and development expenses rose to $13.2M in Q2 2026 from $11.5M in Q2 2025, a 14.4% increase.
• · Selling, general and administrative expenses increased to $13.0M in Q2 2026 from $7.8M in Q2 2025, a 68.2% increase.
• · Accumulated deficit grew to $763.7M as of June 30, 2026 from $501.7M at December 31, 2025.
• · Total assets increased to $832.4M from $500.5M, primarily due to the cash raise.
• · Earnout liability was fully settled in H1 2026, going from $22.6M at year-end 2025 to $0.
• · Basic and diluted net loss per share was $(0.95) in Q2 2026 versus $(0.25) in Q2 2025.
• · Weighted average basic shares outstanding increased to 240.6M in Q2 2026 from 199.0M in Q2 2025.

27-07-2026

Neptune Insurance Holdings Inc. (NP) reported strong revenue growth for Q2 2026, with commissions and fees revenue increasing 32.8% YoY to $55.9M for the quarter and 31.2% YoY to $93.7M for the first half. Net income available to common stockholders swung sharply positive to $15.8M in Q2 2026 from a loss of $46.0M in Q2 2025, driven by the absence of a $54.2M preferred stock dividend paid in the prior year. However, the company's balance sheet remains highly leveraged with $240.0M in revolving credit facility debt and a stockholders' deficit of $222.2M, though the deficit improved from $227.5M at year-end 2025.

• · Employee compensation and benefits surged 451.6% YoY to $8.4M in Q2 2026 (from $1.5M), and 474.4% to $16.8M in H1 2026 (from $2.9M), likely reflecting post-IPO equity compensation.
• · General and administrative expenses declined 40.2% YoY to $3.4M in Q2 2026 and 14.5% to $6.9M in H1 2026.
• · Interest expense decreased 38.2% YoY to $3.6M in Q2 2026 and 13.4% to $7.2M in H1 2026, reflecting debt restructuring.
• · The company repurchased 1,219,000 shares of Class A common stock in Q2 2026 for $31.9M, reducing shares outstanding.
• · No redeemable convertible preferred stock remained outstanding as of June 30, 2026, compared to 41,850 shares at June 30, 2025, following conversion or redemption.
• · Fiduciary cash and fiduciary receivables grew significantly, with fiduciary cash reaching $59.5M (up 83.0% from $32.5M at Dec 31, 2025).
• · Premium deposits liability increased 88.0% to $35.6M from $18.9M at year-end 2025.
• · All outstanding stock options are fully exercisable as of June 30, 2026, with aggregate intrinsic value of $208.4M.

27-07-2026

OPKO Health reported Q2 2026 revenue of $163.6M, up 4.3% YoY, driven by a 208% surge in intellectual property revenue. However, revenue from services declined 26.3% YoY. Net loss narrowed significantly to $8.4M from $148.4M in Q2 2025, aided by a $18.1M gain on asset sales and lower interest expense. Cash and cash equivalents decreased to $300.8M from $369.1M at year-end 2025.

• · Operating loss improved to $7.0M in Q2 2026 from $60.0M in Q2 2025.
• · Selling, general and administrative expenses decreased 11.2% YoY to $52.9M.
• · Research and development expenses increased 9.3% YoY to $33.2M.
• · Cash used in operating activities was $62.8M for H1 2026 vs $118.0M for H1 2025.
• · Total assets decreased to $1.83B from $1.93B at year-end 2025.
• · Accumulated deficit widened to $2.35B from $2.29B.
• · Share repurchases totaled $17.8M in H1 2026.
• · Proceeds from Labcorp sale were $18.4M in H1 2026.

27-07-2026

Baker Hughes reported Q2 2026 revenue of $6,742M, down 2.4% YoY from $6,910M, while net income attributable to the company fell to $681M from $701M. For the first half of 2026, revenue was essentially flat at $13,329M vs $13,337M, but net income rose sharply to $1,611M from $1,103M, boosted by a $697M gain on business dispositions. Cash and cash equivalents surged to $15,727M from $3,715M at year-end 2025, driven by $9,885M in long-term debt issuance.

• · Q2 2026 sales of goods declined 5.0% YoY to $4,292M, while sales of services increased 2.3% to $2,450M.
• · Cost of goods sold fell 8.0% YoY to $3,315M in Q2 2026, but cost of services sold rose 9.3% to $1,850M.
• · Restructuring charges of $11M in Q2 2026 and $50M in H1 2026, compared to zero in the prior-year periods.
• · Other income (expense) net swung to a gain of $104M in Q2 2026 from a gain of $134M, and to a gain of $691M in H1 2026 from an expense of $6M in H1 2025, largely due to the $697M gain on business dispositions.
• · Interest expense net increased to $66M in Q2 2026 from $54M, and to $151M in H1 2026 from $105M, reflecting higher debt levels.
• · Provision for income taxes decreased to $210M in Q2 2026 from $256M, but increased to $545M in H1 2026 from $408M.
• · Net cash from operating activities rose 51.4% to $1,845M in H1 2026, driven by higher net income and favorable working capital changes including a $803M increase in progress collections.
• · Investing activities provided $874M in H1 2026 vs using $596M in H1 2025, primarily due to $1,381M in proceeds from business dispositions.
• · Financing activities provided $9,287M in H1 2026 vs using $945M in H1 2025, driven by $9,885M in long-term debt issuance; no share repurchases occurred in H1 2026 vs $384M in H1 2025.
• · Total assets increased to $52,620M from $40,881M at year-end 2025, largely due to the cash increase.
• · Retained loss improved to ($1,641M) from ($3,252M) at year-end 2025, reflecting net income partially offset by dividends.
• · Accumulated other comprehensive loss worsened to ($2,781M) from ($2,652M), driven by negative foreign currency translation adjustments of $37M in H1 2026.

27-07-2026

DYNEX CAPITAL INC reported a strong turnaround for Q2 2026, with net income of $180.8M for the quarter compared to a net loss of $13.6M in Q2 2025, driven by a significant gain on derivative instruments of $128.8M and higher net interest income of $93.8M. However, the company recorded a large unrealized loss on investments of $25.6M for the quarter and $277.4M for the first half, and its accumulated deficit widened to $567.2M from $441.9M at year-end 2025. Total assets grew 52% to $26.4B, largely funded by a $8.7B increase in repurchase agreements.

• · Total operating expenses increased to $16.2M in Q2 2026 from $12.3M in Q2 2025, a 31.9% rise.
• · Cash and cash equivalents grew to $607.6M as of June 30, 2026 from $531.0M at Dec 31, 2025.
• · Cash collateral posted to counterparties increased to $570.0M from $399.3M.
• · Net cash provided by operating activities was $154.0M for H1 2026 vs $38.2M for H1 2025.
• · Net cash used in investing activities was $9.3B for H1 2026 vs $2.4B for H1 2025, driven by $11.2B in purchases of investments.
• · Net cash provided by financing activities was $9.4B for H1 2026 vs $2.5B for H1 2025, primarily from increased repurchase agreement borrowings.
• · Common stock issuance proceeds totaled $833.0M in H1 2026 vs $521.8M in H1 2025.
• · Dividends paid on common stock were $220.4M in H1 2026 vs $103.2M in H1 2025.
• · Weighted average diluted shares outstanding increased to 223.6M in Q2 2026 from 113.2M in Q2 2025.
• · Accumulated other comprehensive loss slightly worsened to $128.1M from $127.1M at Dec 31, 2025.

27-07-2026

Agilysys Inc reported strong Q1 FY26 results for the quarter ended June 30, 2026, with total net revenue increasing 14.3% YoY to $87.7M, driven by a 18.8% rise in subscription and maintenance revenue to $57.7M. Net income nearly doubled to $9.0M from $4.9M in the prior-year quarter, and operating income more than doubled to $9.7M. However, the company recorded a foreign currency translation loss of $3.4M, which reduced total comprehensive income to $5.6M from $12.1M a year ago, and total assets declined slightly to $472.8M from $481.5M at March 31, 2026.

• · Gross profit margin improved to 63.5% from 61.7% YoY.
• · Product development expenses increased 16.0% YoY to $20.2M.
• · Sales and marketing expenses rose 3.4% YoY to $12.2M.
• · General and administrative expenses increased 3.3% YoY to $11.1M.
• · Interest income more than doubled to $990K from $447K YoY.
• · Income tax provision was $1.8M vs a benefit of $41K in the prior year.
• · Net cash provided by operating activities was $7.8M, compared to cash used of $4.3M in Q1 FY25.
• · Goodwill decreased to $131.6M from $133.9M at March 31, 2026.
• · Contract liabilities (deferred revenue) decreased to $72.9M from $83.0M at March 31, 2026.
• · Accrued liabilities fell sharply to $14.0M from $24.3M, primarily due to lower salaries and wages accruals.
• · Diluted net income per share was $0.32, up from $0.17 in the prior year.
• · Unrealized foreign currency translation loss of $3.4M compared to a gain of $7.2M in Q1 FY25.

27-07-2026

Martin Midstream Partners L.P. reported a net income of $2.6M for Q2 2026, reversing a net loss of $2.4M in Q2 2025, driven by strong revenue growth of 18.2% to $213.6M. However, for the first six months of 2026, the partnership posted a net loss of $4.1M, wider than the $3.4M loss in the prior-year period, as operating income declined 6.9% to $27.3M. Cash flow from operations turned negative at -$1.6M for the six months, compared to positive $24.9M a year ago, reflecting significant working capital outflows.

• · Partners' capital deficit widened to $90.2M as of June 30, 2026 from $85.8M at December 31, 2025.
• · Long-term debt, net increased to $453.7M from $428.0M at year-end 2025.
• · Capital expenditures (property, plant & equipment) were $17.0M in H1 2026, up from $11.2M in H1 2025.
• · Plant turnaround costs totaled $9.4M in H1 2026 vs $1.8M in the prior-year period.
• · Gain on disposition of property, plant and equipment was $4.7M in Q2 2026, compared to $0.6M in Q2 2025.
• · Offshore marine transportation revenue declined 47.4% in Q2 2026 and 44.4% in H1 2026 versus the prior-year periods.

27-07-2026

GeoVax Labs, Inc. reported a net loss of $4.4M for Q2 2026, improved from a $5.4M loss in Q2 2025, driven by lower operating expenses. However, revenue from government contracts fell to zero in 2026 from $0.85M in Q2 2025, and the company's accumulated deficit grew to $160.5M. Cash and cash equivalents remained nearly flat at $3.1M, supported by $7.3M in financing activities from stock and warrant sales.

• · Prepaid clinical trial costs decreased from $1.2M at Dec 2025 to $0.83M at Jun 2026.
• · Prepaid contract manufacturing costs dropped to $0 from $0.78M at Dec 2025.
• · Accounts payable more than doubled from $0.79M to $1.83M.
• · Operating lease right-of-use assets declined from $0.83M to $0.31M.
• · Weighted average shares outstanding increased dramatically from 614,369 in Q2 2025 to 4,565,207 in Q2 2026.
• · Net loss per share improved from ($8.74) to ($0.97) due to share dilution.

27-07-2026

Celestica reported strong Q2 2026 results with revenue of $4,698.6M, up 62.4% YoY, and net earnings of $368.8M, up 74.8% YoY. The Communications and Enterprise segments drove growth, with Enterprise revenue surging 167.2% YoY. However, the ATS segment grew only 8.4% YoY, and total comprehensive income declined sequentially due to negative other comprehensive income of ($6.9M). Cash flow from operations improved significantly, but the company used $342.4M in financing activities in H1 2026, including $326.3M for SBC cash settlement.

• · CCS segment contributed 81% of total revenue in Q2 2026, up from 72% in Q2 2025.
• · ATS segment share declined to 19% of total revenue in Q2 2026 from 28% in Q2 2025.
• · Gross profit margin was 12.3% in Q2 2026 vs 12.8% in Q2 2025.
• · Earnings from operations margin was 9.8% in Q2 2026 vs 9.4% in Q2 2025.
• · Inventories increased 55.5% from $2,188.0M at Dec 31, 2025 to $3,401.7M at June 30, 2026.
• · Accounts payable more than doubled from $1,866.1M to $3,819.7M over the same period.
• · Net cash used in financing activities was $342.4M in H1 2026, compared to $320.5M in H1 2025.
• · The company borrowed $250.0M under term loans in Q2 2026 and repaid $233.7M in H1 2026.
• · Unpaid purchases of property, plant and equipment at end of period were $180.0M, up from $31.4M a year ago.
• · Basic EPS was $3.21 in Q2 2026 vs $1.83 in Q2 2025; diluted EPS was $3.17 vs $1.82.
• · Total comprehensive income was $361.9M in Q2 2026 vs $225.8M in Q2 2025, but other comprehensive loss was ($6.9M) vs income of $14.8M.
• · Restructuring and other charges were $2.9M in Q2 2026 vs $14.5M in Q2 2025; H1 2026 showed a recovery of ($1.5M) vs charges of $18.4M in H1 2025.

27-07-2026

Champions Oncology, Inc. reported a 4.4% increase in oncology revenue to $59.4M for the fiscal year ended April 30, 2026, driven by a 17.6% rise in pharmacology services to $57.1M. However, the company swung to a net loss of $1.2M from a net income of $4.7M in the prior year, as total operating expenses grew 15.6% and TOS data license revenue plummeted 83.7% to $0.8M. Cash and cash equivalents more than halved to $4.9M from $9.8M, and operating cash flow turned negative at -$4.5M.

• · Total operating expenses grew 15.6% to $60.6M, outpacing revenue growth.
• · R&D expense increased 33.1% to $9.1M; sales and marketing rose 23.5% to $9.3M; G&A rose 19.4% to $11.2M.
• · Cost of oncology revenue increased 8.8% to $30.9M, causing gross margin to decline from 50.1% to 48.0%.
• · Deferred revenue dropped 42.8% to $8.8M, indicating a significant reduction in advance payments from customers.
• · Accounts receivable increased 17.6% to $13.2M, while accounts payable rose 62.5% to $6.9M.
• · The company reported a net loss per share of $(0.08) basic and diluted, compared to EPS of $0.34 basic and $0.33 diluted in FY2025.
• · Stock-based compensation expense nearly doubled to $1.2M from $0.7M.
• · Goodwill remained unchanged at $0.3M.
• · Noncontrolling interest of $0.1M appeared in FY2026, absent in FY2025.

27-07-2026

Brown & Brown, Inc. reported strong revenue growth for Q2 2026, with total revenues of $1,676M, up 30.4% from $1,285M in Q2 2025, driven by a 32.4% increase in commissions and fees. Net income attributable to the company rose 24.7% to $288M from $231M. However, comprehensive income attributable to the company fell sharply to $276M from $478M, primarily due to a foreign currency translation loss of $12M versus a gain of $247M in the prior year. The company also increased share repurchases and dividends, while total assets remained relatively flat at $29,887M.

• · Diluted EPS for Q2 2026 was $0.84, up from $0.78 in Q2 2025.
• · Basic EPS for Q2 2026 was $0.86, up from $0.79 in Q2 2025.
• · Total expenses for Q2 2026 were $1,293M, up 32.8% from $974M in Q2 2025.
• · Interest expense for Q2 2026 was $100M, nearly double the $51M in Q2 2025.
• · Amortization expense for Q2 2026 was $110M, more than double the $50M in Q2 2025.
• · The company repurchased $500M of treasury stock in H1 2026, compared to zero in H1 2025.
• · Cash dividends paid increased to $112M in H1 2026 from $86M in H1 2025.
• · Net cash provided by operating activities was $608M in H1 2026, up from $538M in H1 2025.
• · The company had $225M in borrowings on its revolving credit facility in H1 2026.
• · Goodwill increased slightly to $15,146M as of June 30, 2026 from $15,087M at year-end 2025.
• · Total equity was nearly flat at $12,608M vs $12,573M at year-end 2025.

27-07-2026

AtriCure, Inc. reported a strong turnaround in Q2 2026, with net income of $8.96M for the three months ended June 30, 2026, compared to a net loss of $6.19M in the same period last year. Revenue grew 12.8% to $153.6M, driven by higher gross profit, while operating expenses increased modestly. However, the company experienced a foreign currency translation loss of $0.13M in Q2 2026 versus a gain of $0.98M in Q2 2025, and cash flow from operations improved but remained pressured by working capital changes.

• · Foreign currency translation loss of $0.13M in Q2 2026 vs gain of $0.98M in Q2 2025.
• · Accounts receivable increased by $13.78M in H1 2026, driving a working capital cash outflow.
• · Inventories increased by $5.64M in H1 2026, compared to a $0.07M increase in H1 2025.
• · Accrued liabilities decreased by $10.06M in H1 2026, a cash outflow vs a $5.83M decrease in H1 2025.
• · Share-based compensation expense rose to $23.6M in H1 2026 from $21.0M in H1 2025.
• · Net cash used in financing activities increased to $9.99M in H1 2026 from $6.91M in H1 2025, partly due to $11.76M in share repurchases for tax withholdings.
• · Total assets grew to $676.6M as of June 30, 2026 from $654.2M at year-end 2025.
• · Goodwill remained unchanged at $234.8M.
• · Intangible assets, net decreased to $43.3M from $48.0M due to amortization.
• · No acquisitions or in-process R&D expenses were recorded in H1 2026, compared to $5.0M in H1 2025.

27-07-2026

Gorman-Rupp Co (GRC) reported strong financial results for Q2 and H1 2026, with net sales increasing 3.9% YoY to $186.1M in Q2 and 5.7% to $362.7M in H1. Net income rose 23.0% to $19.4M in Q2 and 33.5% to $37.3M in H1, driven by improved gross margins and lower interest expense. However, the Fire end market declined 7.0% in Q2 and 11.7% in H1, and the Petroleum and Repair Parts segments also showed weakness, partially offsetting gains in Agriculture, Construction, and Industrial markets.

• · Gross profit margin improved to 32.6% in Q2 2026 from 31.3% in Q2 2025.
• · SG&A expenses increased 4.1% YoY to $27.1M in Q2 2026.
• · Inventory decreased 9.7% from $96.5M at Dec 2025 to $87.1M at June 2026.
• · Accounts receivable increased 22.0% from $88.4M at Dec 2025 to $107.8M at June 2026.
• · Total debt decreased 3.3% from $307.5M at Dec 2025 to $275.0M at June 2026.
• · Capital additions increased 31.5% to $7.9M in H1 2026 from $6.0M in H1 2025.
• · Treasury share repurchases increased to $2.6M in H1 2026 from $1.2M in H1 2025.
• · Cash dividend increased 2.7% to $0.19 per share quarterly from $0.185.
• · Accumulated other comprehensive loss widened to $(20.8)M from $(20.4)M.

27-07-2026

SEI Investments reported mixed Q2 2026 results. Total revenues increased 14.6% YoY to $641.6M for the quarter, driven by strong asset management and administration fees (+17.4% to $513.5M). However, net income attributable to SEI fell 13.8% YoY to $195.7M, and diluted EPS declined 10.7% to $1.59, primarily due to the absence of a $94.4M gain on sale of business recorded in Q2 2025. For the six-month period, revenues grew 13.8% to $1.26B, while net income attributable to SEI slipped 2.2% to $370.1M.

• · Operating cash flow increased 42.9% to $347.4M in H1 2026 from $243.0M in H1 2025.
• · Total assets grew 2.0% to $3.32B at June 30, 2026 from $3.26B at December 31, 2025.
• · Goodwill increased 9.7% to $389.4M from $355.0M, and intangible assets rose 27.8% to $470.5M from $368.3M, likely reflecting acquisitions.
• · Long-term debt of $29.5M was recorded at June 30, 2026 versus zero at year-end 2025.
• · Redeemable non-controlling interests increased 27.5% to $311.0M from $244.0M.
• · The company repurchased 3.847 million shares for $320.7M in H1 2026, reducing outstanding shares by 3.1%.
• · Dividend per share increased 6.1% to $0.52 from $0.49 in the prior year quarter.

27-07-2026

Webster Financial Corp reported mixed Q2 2026 results. Net income for Q2 2026 was $256.8M, slightly down from $258.8M in Q2 2025, while H1 2026 net income rose to $503.0M from $485.8M. Diluted EPS improved to $1.56 (Q2) and $3.05 (H1) from $1.52 and $2.81 respectively. However, net interest margin (FTE) declined to 3.26% (Q2) and 3.31% (H1) from 3.44% and 3.46%, and the efficiency ratio worsened to 47.74% (Q2) and 47.28% (H1) from 45.40% and 45.59%. Non-interest income grew strongly, but non-interest expense rose faster, and asset quality improved with non-performing assets falling to $430.2M from $537.1M.

• · Net interest income increased 1.9% YoY in Q2 2026 to $632.7M, driven by volume growth offsetting rate compression.
• · Non-interest income grew 13.3% YoY in Q2 2026, led by other income (+34.2%) and loan/lease related fees (+16.5%).
• · Non-interest expense rose 11.4% YoY in Q2 2026, with compensation and benefits up 12.2% and technology and equipment up 10.0%.
• · The efficiency ratio (non-GAAP) worsened to 47.74% in Q2 2026 from 45.40% in Q2 2025, indicating higher costs relative to revenue.
• · Net charge-offs / average loans and leases (annualized) increased to 0.30% in Q2 2026 from 0.27% in Q2 2025.
• · ACL on loans and leases / non-performing loans and leases improved to 168.72% from 135.08%, reflecting stronger coverage.
• · Total assets grew 4.9% YoY to $85.95B as of June 30, 2026.
• · All regulatory capital ratios improved: CET1 to 11.71% (from 11.35%), Tier 1 to 12.20% (from 11.86%), Total to 14.16% (from 14.05%).
• · Average loans and leases increased 8.0% YoY in Q2 2026 to $57.56B.
• · Average total deposits grew 5.8% YoY in Q2 2026 to $69.80B, with interest-bearing checking up 24.0% and money market up 10.7%.
• · Average FHLB advances increased 76.7% YoY in Q2 2026 to $4.68B.
• · The yield on interest-earning assets declined to 5.12% in Q2 2026 from 5.44% in Q2 2025, while the cost of interest-bearing liabilities fell to 2.02% from 2.18%.
• · Transaction expenses of $8.7M in Q2 2026 and $17.9M in H1 2026 impacted non-interest expense.
• · Strategic restructuring costs of $3.6M were recorded in H1 2026.
• · FDIC special assessment credit of $0.7M was recorded in H1 2026.